RK

Rohtas Kumar

Active Director Director DIN 10055436
DIN 10055436 First appointment Feb 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Rohtas Kumar

Data last updated:

Rohtas Kumar is a Director at Unicus Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Unicus Pharmaceuticals Private Limited reported revenue of ₹5.5 Lakh (FY 2024).

DIN 10055436
Primary Designation Director
Industry Pharma
First Appointment 24 Feb 2023
Oldest Company Age 3 yrs
Largest company Unicus Pharmaceuticals Private Limited · ₹5.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Feb 20232023₹5.5 Lakh (FY 2024)Active

Board colleagues of Rohtas Kumar

Directorship timeline

Open interactive timeline →
Unicus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rohtas Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohtas Kumar

Rohtas Kumar currently holds 1 directorship: Unicus Pharmaceuticals Private Limited (Director, since 24 Feb 2023, revenue ₹5.5 Lakh (FY 2024)).

Rohtas Kumar was first appointed on 24 Feb 2023 as Director at Unicus Pharmaceuticals Private Limited.

The current boards of Rohtas Kumar's companies include Dhan Prasad (Unicus Pharmaceuticals Private Limited), Rohit Kumar (Unicus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available